Cart
sales@molnova.com
SNX-0723
CAS No. 1073969-18-2
SNX-0723( SNX 0723 | SNX0723 )
Catalog No. M10305 CAS No. 1073969-18-2
SNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 206 | In Stock |
|
| 5MG | 188 | In Stock |
|
| 10MG | 316 | In Stock |
|
| 25MG | 511 | In Stock |
|
| 50MG | 686 | In Stock |
|
| 100MG | 921 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSNX-0723
-
NoteResearch use only, not for human use.
-
Brief DescriptionSNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM.
-
DescriptionSNX-0723 is a selective, brain-permeable, orally acitve small-molecule inhibitor of Hsp90 (IC50=14 nM) that inhibits alpha-synuclein oligomerization with EC50 of 48 nM; induces Hsp70 (IC50=31 nM), and decreases expression of several known Hsp90 client proteins:HER2 (IC50=9.4 nM), ribosomal protein s6 (pS6) (IC50=13 nM), and PERK (IC50=5.5 nM); shows significant brain concentrations along with induction of brain Hsp70 in vivo with promising PK properties.
-
In Vitro——
-
In Vivo——
-
SynonymsSNX 0723 | SNX0723
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetHSP
-
RecptorHSP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1073969-18-2
-
Formula Weight399.47
-
Molecular FormulaC22H26FN3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20.83 mg/mL (52.15 mM)
-
SMILESO=C(N)C1=C(N[C@@H]2COCC2)C=C(N3C=C(C)C4=C3CC(C)(C)CC4=O)C=C1F
-
Chemical Name2-fluoro-6-[[(3S)-oxolan-3-yl]amino]-4-(3,6,6-trimethyl-4-oxo-5,7-dihydroindol-1-yl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Putcha P, J Pharmacol Exp Ther. 2010 Mar;332(3):849-57.et al.
2. McFarland NR, et al. PLoS One. 2014 Jan 20;9(1):e86048.
3. Neubert T, et al. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1338-42.
molnova catalog
related products
-
Alvespimycin hydroch...
A potent, orally bioavailable Hsp90 inhibitor with binding EC50 of 62 nM.
-
PU-WS13
A potent and selective Grp94 inhibitor with Ic50 of 0.22 uM.
-
Arimoclomol maleate
Arimoclomol maleate (BRX-220) is a heat shock protein (HSP) co-inducer.
